nodes	percent_of_prediction	percent_of_DWPC	metapath
Alpha-Linolenic Acid—TRPV1—spinal nerve—multiple sclerosis	0.177	0.197	CbGeAlD
Alpha-Linolenic Acid—TRPV1—sciatic nerve—multiple sclerosis	0.114	0.127	CbGeAlD
Alpha-Linolenic Acid—TRPV1—trigeminal nerve—multiple sclerosis	0.0933	0.104	CbGeAlD
Alpha-Linolenic Acid—TRPV1—peripheral nervous system—multiple sclerosis	0.0437	0.0486	CbGeAlD
Alpha-Linolenic Acid—TRPV1—nerve—multiple sclerosis	0.0341	0.0379	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—retina—multiple sclerosis	0.0212	0.0235	CbGeAlD
Alpha-Linolenic Acid—FADS2—retina—multiple sclerosis	0.018	0.02	CbGeAlD
Alpha-Linolenic Acid—FABP7—brainstem—multiple sclerosis	0.0161	0.0179	CbGeAlD
Alpha-Linolenic Acid—FABP7—retina—multiple sclerosis	0.0156	0.0173	CbGeAlD
Alpha-Linolenic Acid—FABP3—spinal cord—multiple sclerosis	0.0153	0.017	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—medulla oblongata—multiple sclerosis	0.0153	0.017	CbGeAlD
Alpha-Linolenic Acid—FADS1—retina—multiple sclerosis	0.0141	0.0157	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—midbrain—multiple sclerosis	0.014	0.0155	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—spinal cord—multiple sclerosis	0.0136	0.0152	CbGeAlD
Alpha-Linolenic Acid—FADS2—medulla oblongata—multiple sclerosis	0.013	0.0145	CbGeAlD
Alpha-Linolenic Acid—FABP3—nervous system—multiple sclerosis	0.0129	0.0143	CbGeAlD
Alpha-Linolenic Acid—FABP3—central nervous system—multiple sclerosis	0.0124	0.0138	CbGeAlD
Alpha-Linolenic Acid—FADS2—midbrain—multiple sclerosis	0.0119	0.0132	CbGeAlD
Alpha-Linolenic Acid—FADS2—spinal cord—multiple sclerosis	0.0116	0.0129	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—nervous system—multiple sclerosis	0.0115	0.0128	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—nervous system—multiple sclerosis	0.0115	0.0128	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—central nervous system—multiple sclerosis	0.0111	0.0123	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—central nervous system—multiple sclerosis	0.0111	0.0123	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—cerebellum—multiple sclerosis	0.0108	0.012	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—Ectoderm Differentiation—AHI1—multiple sclerosis	0.0106	0.121	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—medulla oblongata—multiple sclerosis	0.0102	0.0114	CbGeAlD
Alpha-Linolenic Acid—FABP7—spinal cord—multiple sclerosis	0.01	0.0112	CbGeAlD
Alpha-Linolenic Acid—FABP3—brain—multiple sclerosis	0.00985	0.011	CbGeAlD
Alpha-Linolenic Acid—FADS2—nervous system—multiple sclerosis	0.00977	0.0109	CbGeAlD
Alpha-Linolenic Acid—FADS2—central nervous system—multiple sclerosis	0.00941	0.0105	CbGeAlD
Alpha-Linolenic Acid—FADS1—midbrain—multiple sclerosis	0.00932	0.0104	CbGeAlD
Alpha-Linolenic Acid—FADS2—cerebellum—multiple sclerosis	0.00919	0.0102	CbGeAlD
Alpha-Linolenic Acid—TRPV1—spinal cord—multiple sclerosis	0.0091	0.0101	CbGeAlD
Alpha-Linolenic Acid—FADS1—spinal cord—multiple sclerosis	0.0091	0.0101	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—brain—multiple sclerosis	0.00878	0.00977	CbGeAlD
Alpha-Linolenic Acid—ELOVL4—brain—multiple sclerosis	0.00878	0.00977	CbGeAlD
Alpha-Linolenic Acid—FABP7—nervous system—multiple sclerosis	0.00845	0.0094	CbGeAlD
Alpha-Linolenic Acid—FABP7—central nervous system—multiple sclerosis	0.00813	0.00905	CbGeAlD
Alpha-Linolenic Acid—FABP7—cerebellum—multiple sclerosis	0.00795	0.00885	CbGeAlD
Alpha-Linolenic Acid—TRPV1—nervous system—multiple sclerosis	0.00767	0.00853	CbGeAlD
Alpha-Linolenic Acid—FADS2—brain—multiple sclerosis	0.00747	0.00831	CbGeAlD
Alpha-Linolenic Acid—TRPV1—central nervous system—multiple sclerosis	0.00738	0.00821	CbGeAlD
Alpha-Linolenic Acid—FADS1—cerebellum—multiple sclerosis	0.00721	0.00803	CbGeAlD
Alpha-Linolenic Acid—FABP7—brain—multiple sclerosis	0.00646	0.00719	CbGeAlD
Alpha-Linolenic Acid—TRPV1—brain—multiple sclerosis	0.00586	0.00652	CbGeAlD
Alpha-Linolenic Acid—FADS1—brain—multiple sclerosis	0.00586	0.00652	CbGeAlD
Alpha-Linolenic Acid—SLC8A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.00559	0.0639	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Calcium Regulation in the Cardiac Cell—RGS1—multiple sclerosis	0.0029	0.0332	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—RGS1—multiple sclerosis	0.00281	0.0321	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGA4—multiple sclerosis	0.00263	0.0301	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.0025	0.0286	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00245	0.0281	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00245	0.0281	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00196	0.0224	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00196	0.0224	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.00189	0.0217	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—MERTK—multiple sclerosis	0.0018	0.0206	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—CD58—multiple sclerosis	0.0018	0.0206	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SELPLG—multiple sclerosis	0.0018	0.0206	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—SRM—multiple sclerosis	0.00155	0.0177	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.00149	0.017	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.00149	0.017	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Trk receptor signaling mediated by the MAPK pathway—MAPK1—multiple sclerosis	0.00145	0.0166	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Ectoderm Differentiation—CCL2—multiple sclerosis	0.00134	0.0153	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.00132	0.0151	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00127	0.0145	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—SRM—multiple sclerosis	0.00124	0.0142	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.00123	0.014	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—PLEK—multiple sclerosis	0.00111	0.0127	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP24A1—multiple sclerosis	0.00109	0.0125	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—CYP27B1—multiple sclerosis	0.00109	0.0125	CbGpPWpGaD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Fingolimod—multiple sclerosis	0.00107	0.0778	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.00107	0.0122	CbGpPWpGaD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Fingolimod—multiple sclerosis	0.00105	0.0762	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—GPC5—multiple sclerosis	0.001	0.0114	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000962	0.011	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—SRM—multiple sclerosis	0.00094	0.0108	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	0.000929	0.0106	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP27B1—multiple sclerosis	0.000874	0.01	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—CYP24A1—multiple sclerosis	0.000874	0.01	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000854	0.00977	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—RRM1—multiple sclerosis	0.000828	0.00948	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—GPC5—multiple sclerosis	0.000799	0.00914	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Ectoderm Differentiation—MYC—multiple sclerosis	0.000792	0.00907	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—SELE—multiple sclerosis	0.000783	0.00896	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.00076	0.0087	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	0.000734	0.0084	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000672	0.00769	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—RRM1—multiple sclerosis	0.000662	0.00758	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP27B1—multiple sclerosis	0.000662	0.00758	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—CYP24A1—multiple sclerosis	0.000662	0.00758	CbGpPWpGaD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	0.000649	0.00743	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	0.000647	0.0074	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000643	0.00735	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—GPC5—multiple sclerosis	0.000606	0.00693	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL1B—multiple sclerosis	0.000586	0.00671	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ITGA4—multiple sclerosis	0.000566	0.00648	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IFNB1—multiple sclerosis	0.000562	0.00643	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000552	0.00632	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000514	0.00588	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Fingolimod—multiple sclerosis	0.000506	0.0366	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000503	0.00576	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—RRM1—multiple sclerosis	0.000502	0.00574	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	0.000476	0.00545	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—BCHE—multiple sclerosis	0.000476	0.00544	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000441	0.00505	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Fingolimod—multiple sclerosis	0.000415	0.03	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Cladribine—multiple sclerosis	0.000407	0.0295	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000402	0.0046	CbGpPWpGaD
Alpha-Linolenic Acid—Aspartate aminotransferase increased—Mitoxantrone—multiple sclerosis	0.0004	0.029	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Mitoxantrone—multiple sclerosis	0.000392	0.0284	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	0.000389	0.00445	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IL2RA—multiple sclerosis	0.000387	0.00442	CbGpPWpGaD
Alpha-Linolenic Acid—ELOVL4—Metabolism—BCHE—multiple sclerosis	0.00038	0.00435	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL6—multiple sclerosis	0.000343	0.00393	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	0.000334	0.00383	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	0.000305	0.00349	CbGpPWpGaD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Methylprednisolone—multiple sclerosis	0.000295	0.0214	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—BCHE—multiple sclerosis	0.000288	0.0033	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.000287	0.0208	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—APOE—multiple sclerosis	0.000286	0.00327	CbGpPWpGaD
Alpha-Linolenic Acid—Constipation—Cladribine—multiple sclerosis	0.000284	0.0206	CcSEcCtD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—ALB—multiple sclerosis	0.00028	0.0032	CbGpPWpGaD
Alpha-Linolenic Acid—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000262	0.019	CcSEcCtD
Alpha-Linolenic Acid—FADS2—Metabolism—POMC—multiple sclerosis	0.000246	0.00281	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000242	0.00277	CbGpPWpGaD
Alpha-Linolenic Acid—Pruritus—Cladribine—multiple sclerosis	0.000235	0.017	CcSEcCtD
Alpha-Linolenic Acid—Alanine aminotransferase increased—Prednisone—multiple sclerosis	0.000234	0.0169	CcSEcCtD
Alpha-Linolenic Acid—TRPV1—Transmembrane transport of small molecules—ALB—multiple sclerosis	0.000234	0.00267	CbGpPWpGaD
Alpha-Linolenic Acid—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.000233	0.0169	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—APOE—multiple sclerosis	0.000229	0.00262	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—IL2—multiple sclerosis	0.000227	0.00259	CbGpPWpGaD
Alpha-Linolenic Acid—FADS2—Metabolism—ALB—multiple sclerosis	0.000224	0.00256	CbGpPWpGaD
Alpha-Linolenic Acid—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000218	0.0158	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Cladribine—multiple sclerosis	0.000211	0.0153	CcSEcCtD
Alpha-Linolenic Acid—Rash—Cladribine—multiple sclerosis	0.00021	0.0152	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Cladribine—multiple sclerosis	0.000209	0.0152	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Methylprednisolone—multiple sclerosis	0.000202	0.0146	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Triamcinolone—multiple sclerosis	0.000198	0.0143	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—POMC—multiple sclerosis	0.000197	0.00225	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000192	0.0139	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Mitoxantrone—multiple sclerosis	0.000187	0.0135	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000179	0.013	CcSEcCtD
Alpha-Linolenic Acid—ELOVL4—Metabolism—ALB—multiple sclerosis	0.000179	0.00205	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—TGFB1—multiple sclerosis	0.000177	0.00202	CbGpPWpGaD
Alpha-Linolenic Acid—SLC8A1—Hemostasis—MAPK1—multiple sclerosis	0.000173	0.00198	CbGpPWpGaD
Alpha-Linolenic Acid—FADS1—Metabolism—APOE—multiple sclerosis	0.000173	0.00198	CbGpPWpGaD
Alpha-Linolenic Acid—Vomiting—Azathioprine—multiple sclerosis	0.000172	0.0124	CcSEcCtD
Alpha-Linolenic Acid—Rash—Azathioprine—multiple sclerosis	0.00017	0.0123	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Azathioprine—multiple sclerosis	0.00017	0.0123	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000165	0.0119	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000164	0.0119	CcSEcCtD
Alpha-Linolenic Acid—Malnutrition—Prednisone—multiple sclerosis	0.00016	0.0116	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.00015	0.0108	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Betamethasone—multiple sclerosis	0.00015	0.0108	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—POMC—multiple sclerosis	0.000149	0.0017	CbGpPWpGaD
Alpha-Linolenic Acid—Dyspepsia—Triamcinolone—multiple sclerosis	0.000145	0.0105	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000145	0.0105	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Mitoxantrone—multiple sclerosis	0.000139	0.0101	CcSEcCtD
Alpha-Linolenic Acid—Rash—Mitoxantrone—multiple sclerosis	0.000138	0.00997	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Mitoxantrone—multiple sclerosis	0.000138	0.00996	CcSEcCtD
Alpha-Linolenic Acid—FADS1—Metabolism—ALB—multiple sclerosis	0.000136	0.00155	CbGpPWpGaD
Alpha-Linolenic Acid—Malnutrition—Methotrexate—multiple sclerosis	0.000133	0.00965	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Betamethasone—multiple sclerosis	0.000132	0.00953	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Dexamethasone—multiple sclerosis	0.000132	0.00953	CcSEcCtD
Alpha-Linolenic Acid—Dysgeusia—Methotrexate—multiple sclerosis	0.000131	0.00945	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Prednisone—multiple sclerosis	0.00013	0.00943	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000129	0.00935	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000129	0.00935	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Triamcinolone—multiple sclerosis	0.000117	0.00844	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Methylprednisolone—multiple sclerosis	0.000116	0.00842	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Prednisone—multiple sclerosis	0.000115	0.0083	CcSEcCtD
Alpha-Linolenic Acid—Rash—Prednisolone—multiple sclerosis	0.000113	0.00818	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Prednisolone—multiple sclerosis	0.000113	0.00817	CcSEcCtD
Alpha-Linolenic Acid—Constipation—Prednisone—multiple sclerosis	0.000111	0.00806	CcSEcCtD
Alpha-Linolenic Acid—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000109	0.00788	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Dexamethasone—multiple sclerosis	0.000106	0.00766	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Betamethasone—multiple sclerosis	0.000106	0.00766	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Triamcinolone—multiple sclerosis	0.000105	0.00759	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Methylprednisolone—multiple sclerosis	0.000105	0.00757	CcSEcCtD
Alpha-Linolenic Acid—Rash—Triamcinolone—multiple sclerosis	0.000104	0.00752	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Triamcinolone—multiple sclerosis	0.000104	0.00752	CcSEcCtD
Alpha-Linolenic Acid—Rash—Methylprednisolone—multiple sclerosis	0.000104	0.00751	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Methylprednisolone—multiple sclerosis	0.000104	0.0075	CcSEcCtD
Alpha-Linolenic Acid—Dyspepsia—Methotrexate—multiple sclerosis	9.58e-05	0.00694	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Betamethasone—multiple sclerosis	9.51e-05	0.00688	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Dexamethasone—multiple sclerosis	9.51e-05	0.00688	CcSEcCtD
Alpha-Linolenic Acid—Rash—Betamethasone—multiple sclerosis	9.43e-05	0.00683	CcSEcCtD
Alpha-Linolenic Acid—Rash—Dexamethasone—multiple sclerosis	9.43e-05	0.00683	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Dexamethasone—multiple sclerosis	9.42e-05	0.00682	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Betamethasone—multiple sclerosis	9.42e-05	0.00682	CcSEcCtD
Alpha-Linolenic Acid—Gastrointestinal disorder—Methotrexate—multiple sclerosis	9.4e-05	0.0068	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Prednisone—multiple sclerosis	9.22e-05	0.00667	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Prednisone—multiple sclerosis	8.28e-05	0.00599	CcSEcCtD
Alpha-Linolenic Acid—Rash—Prednisone—multiple sclerosis	8.21e-05	0.00594	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Prednisone—multiple sclerosis	8.2e-05	0.00594	CcSEcCtD
Alpha-Linolenic Acid—Pruritus—Methotrexate—multiple sclerosis	7.7e-05	0.00557	CcSEcCtD
Alpha-Linolenic Acid—Vomiting—Methotrexate—multiple sclerosis	6.92e-05	0.00501	CcSEcCtD
Alpha-Linolenic Acid—Rash—Methotrexate—multiple sclerosis	6.86e-05	0.00497	CcSEcCtD
Alpha-Linolenic Acid—Dermatitis—Methotrexate—multiple sclerosis	6.86e-05	0.00496	CcSEcCtD
